Related Experiment Video
Updated: May 21, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Recent advances in the development of selective CB(2) agonists as promising anti-inflammatory agents
N Leleu-Chavain1, M Body-Malapel, J Spencer
1Institut de Chimie Pharmaceutique Albert Lespagnol, Université Lille Nord de France, EA 4481, IFR114, 3 rue du Pr. Laguesse, B.P. 83, F-59006 Lille, France.
Abstract:
The high distribution of CB(2) receptors in immune cells suggests their important role in the control of inflammation. Growing evidence offers this receptor as an attractive therapeutic target: CB(2) selective agonists are able to modulate inflammation without triggering psychotropic effects. This review will summarize the literature on the implication of CB(2) in inflammation and CB(2) selective agonists with anti-inflammatory activity.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Direct-Acting Cholinergic Agonists: Therapeutic Uses